Fremont, CA, United States of America

Valdimir Podust

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valdimir Podust: Innovator in Cancer Biomarkers

Introduction

Valdimir Podust is a notable inventor based in Fremont, CA, who has made significant contributions to the field of cancer diagnostics. His work focuses on identifying biomarkers that can aid in the early detection and classification of ovarian and endometrial cancers. With a keen interest in medical innovations, Podust has developed a patented technology that holds promise for improving patient outcomes.

Latest Patents

Valdimir Podust holds a patent for a groundbreaking invention titled "Biomarker for ovarian and endometrial cancer: hepcidin." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrial cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer. A panel of biomarkers, including hepcidin, transthyretin, and optionally other markers, is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry, showcasing a novel approach to cancer diagnostics.

Career Highlights

Throughout his career, Valdimir Podust has worked with prominent organizations, including Vermillion, Inc. and The Johns Hopkins University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.

Collaborations

Some of his notable coworkers include Zhen Zhang and Eric Thomas Fung. Their collaborative efforts have further enhanced the research and development of cancer biomarkers, leading to innovative solutions in the medical field.

Conclusion

Valdimir Podust's contributions to cancer diagnostics through his patented biomarker technology exemplify the impact of innovation in healthcare. His work not only advances scientific understanding but also holds the potential to improve patient care and outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…